哌柏西利联合来曲唑在HR+/HER2-复发转移性乳腺癌患者中的应用

哌柏西利联合来曲唑在HR+/HER2-复发转移性乳腺癌患者中的应用

Heilongjiang Medicine and Pharmacy ›› 2025, Vol. 48 ›› Issue (05) : 153-154+157.

Author information +

History +

CLC number

R737.9

Cite this article

Download Citations

Comments

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉